Paper6380705
Glutathione metabolism as a determinant of therapeutic efficacy: a review.
Arrick BA and 1 other. Cancer Res, 1984. Cited by 499 papers, by iCite.
Cite this record
ConductScience Library. Glutathione metabolism as a determinant of therapeutic efficacy: a review. Papers, record 6380705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6380705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Glutathione | Major topic |
| Neoplasms | Major topic |
| Aminoacridines | |
| Amsacrine | |
| Animals | |
| Biological Transport | |
| Carmustine | |
| Cyclophosphamide | |
| Cytochrome P-450 Enzyme System | |
| Humans | |
| Mechlorethamine | |
| Melphalan | |
| Mercaptopurine | |
| Mice | |
| Neoplasms, Experimental |
Source PubMed
Cited by105
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 499 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42117763 | Effects of Chemotherapeutic Agents (5-Fluorouracil, Cisplatin and Methotrexate) on Cell Adhesion Molecules and Oxidative Damage Markers in Rat Kidney Tissue. | Basic Clin Pharmacol Toxicol | 2026 | https://conductscience.org/library/papers/42117763 | PubMed |
| 42105281 | Gut microbiota-regulated glutathione metabolic rhythms restore obesity-induced colonic inflammatory oscillations. | Gut Microbes | 2026 | https://conductscience.org/library/papers/42105281 | PubMed |
| 41897500 | A Targeted Metabolomic Assessment of Oral Glutathione Bioavailability and Safety in Humans: A Randomized Crossover Clinical Trial. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41897500 | PubMed |
| 39456484 | Evaluation of Glutathione (GSH) System in Porcine Saliva: Validation and Application of Colorimetric Method. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39456484 | PubMed |
| 37731484 | Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions. | Front Immunol | 2023 | https://conductscience.org/library/papers/37731484 | PubMed |
| 36132317 | Nanomaterials for the regulation of the tumor microenvironment and theranostics. | Nanoscale Adv | 2020 | https://conductscience.org/library/papers/36132317 | PubMed |
| 36014491 | Glutathione-Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation. | Molecules | 2022 | https://conductscience.org/library/papers/36014491 | PubMed |
| 35606848 | Tumor microenvironment responsive Mn3O4 nanoplatform for in vivo real-time monitoring of drug resistance and photothermal/chemodynamic synergistic therapy of gastric cancer. | J Nanobiotechnology | 2022 | https://conductscience.org/library/papers/35606848 | PubMed |
| 34822010 | Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines. | Metabolomics | 2021 | https://conductscience.org/library/papers/34822010 | PubMed |
| 34729312 | Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/34729312 | PubMed |
| 33168599 | Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum. | Mol Cancer Res | 2021 | https://conductscience.org/library/papers/33168599 | PubMed |
| 32526885 | Glutathione S-Transferase pi-1 Knockdown Reduces Pancreatic Ductal Adenocarcinoma Growth by Activating Oxidative Stress Response Pathways. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32526885 | PubMed |
| 31980738 | Amino acids in cancer. | Exp Mol Med | 2020 | https://conductscience.org/library/papers/31980738 | PubMed |
| 29949936 | Glutathione in Ovarian Cancer: A Double-Edged Sword. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29949936 | PubMed |
| 29330550 | A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates. | Sci Rep | 2018 | https://conductscience.org/library/papers/29330550 | PubMed |
| 28962432 | Erectile dysfunction drugs and oxidative stress in the liver of male rats. | Toxicol Rep | 2015 | https://conductscience.org/library/papers/28962432 | PubMed |
| 28620280 | Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. | Front Mol Neurosci | 2017 | https://conductscience.org/library/papers/28620280 | PubMed |
| 27455336 | Stimuli-Responsive Gold Nanoparticles for Cancer Diagnosis and Therapy. | J Funct Biomater | 2016 | https://conductscience.org/library/papers/27455336 | PubMed |
| 27270209 | Modulation of oxidative stress and subsequent induction of apoptosis and endoplasmic reticulum stress allows citral to decrease cancer cell proliferation. | Sci Rep | 2016 | https://conductscience.org/library/papers/27270209 | PubMed |
| 24935758 | Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levels. | J Magn Reson Imaging | 2015 | https://conductscience.org/library/papers/24935758 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6380705
GET https://conductscience.org/api/papers/v1/6380705/cited_by?page=2